BRANMOOR
THURSDAY ยท 14 MAY 2026

FDA Recall D-0151-2025

Apothecus Pharmaceutical Corp. · Hicksville, NY

Class II Ongoing 538 days on record

Moderate impact — Class II recall โ€” temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.

Product

VCF, Vaginal Contraceptive Gel, Birth Control, 10 Pre-filled Applicators, Net Wt. 0.09 oz (2.55g) Each, Distributed By: Apothecus Pharmaceutical Corp., Ronkonkoma, NY 11779, NDC 52925-512-10

Lot / code: Lot: 3A001/3A001A, Exp: 07/25

Quantity: 33,659 retail boxes in US

Reason for recall

CGMP deviations: out of specifications for assay

Recall record

Recall number
D-0151-2025
Classification
Class II
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Letter
Distribution
Nationwide in the USA and 2 Distributors in Hong Kong
Recall initiated
2024-11-22
Classified by FDA Center
2024-12-17
FDA published
2024-12-25
Recalling firm
Apothecus Pharmaceutical Corp.
Firm location
Hicksville, NY

Drug identification

Brand name(s)
VCF CONTRACEPTIVE PRE-FILLED APPLICATORS
Generic name(s)
NONOXYNOL-9
Manufacturer(s)
APOTHECUS PHARMACEUTICAL CORP
NDC(s)
52925-512
Route(s)
VAGINAL

Operational response

Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls